CBCT Guided Markerless SBRT for Renal Cell Cancer
ConditionRenal Cell Carcinoma (RCC)
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorErasmus Medical Center
About this trial
This study aims to improve the treatment of kidney tumors using radiotherapy, by investigating whether kidney cancer can be more effectively irradiated with the help of new imaging techniques
Eligibility criteria
Qualifiers
Patients with histologically proven non-metastastic RCC or high suspicion of RCC based on imaging without histological evidence
No metastatic lesions
Patients must be 18 years or older
Ability to understand the requirements of the study and to give written informed consent, as determined by the treating physician.
Disqualifiers
Previous high-dose radiotherapy in the region of the kidney
Trial design
Treatments tested in this trial
- Additional radiation due to imaging
Treatment groups
40 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov